Acuta Capital Partners, LLC 4 D Molecular Therapeutics, Inc. Transaction History

Acuta Capital Partners, LLC

  • $98.8 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$9.76 - $21.25 $727,120 - $1.58 Million
74,500 New
74,500 $1.51 Million
Q1 2023

May 15, 2023
BUY
$15.45 - $23.19 $1.62 Million - $2.43 Million
104,753 New
104,753 $1.8 Million
Q2 2021

Aug 16, 2021
SELL
$22.2 - $42.29 $444,000 - $845,800
-20,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$38.43 - $47.36 $768,600 - $947,200
20,000 New
20,000 $829,000

Others Institutions Holding FDMT

# of Institutions
144
Shares Held
57.7M
Call Options Held
137K
Put Options Held
111K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $272M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email